Multiple sclerosis (MS) is a chronic inflammatory disorder that is thought to impact about 2.3 million people around the ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

Scientists have uncovered how a protein helps build and maintain vital brain connections, providing insights into the ...

There is some promising research, but at this time, there doesn't appear to be an effective method of multiple sclerosis prevention. Here's what research has found so far.

Tau protein is essential for microtubule stability and neuronal function. The protein’s disfunction is linked to several ...

Relapsing-remitting MS (RRMS) RRMS is the most common type of the disease. According to the National Multiple Sclerosis Society, about 85% of people with MS have RRMS at the time of diagnosis.

News about Vladimir Putin, including commentary and archival articles published in The New York Times.